Ephedrine and its salts

in preparations containing more than 8 mg per unit dose, or with a label recommending more than 8 mg/dose or 32 mg/day, or labelled or implied for use exceeding 7 days, or if indicated for other than nasal congestion.

Approval Date: February 23, 2002

Schedule: I

Footnote: